Short‐term survivors and LTS with IDH‐wildtype GB have very different survival profiles but, surprisingly, only a few tumor and serum proteins were found to be differentially expressed between these two groups in DIA‐MS‐based proteomics analyses. This evidence concerns the gene IDH1 and neoplasm.